cariprazine
Ligand Summary
The efficacy of cariprazine could be mediated through a combination of partial agonist activity at central dopamine D2 and serotonin 5-HT1A receptors and antagonist activity at serotonin 5-HT2A receptors.
UNII: F6RJL8B278
PubChem: 11154555
Guide to Pharmacology: 7671
ChEMBL: CHEMBL2028019
ChEMBL: CHEMBL2024517
DrugCentral: 5037
LyCHI: P9ZB9T1NVV9U
Target Activities
51 Activities
Items per page:
1 – 10 of 51
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
Ki | ||||||
Ki | ||||||
EC50 | ||||||
Ki | ||||||
Ki | ||||||
EC50 | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||